Arnold J Levine
CIK 1124164 · last filed 2026-06-05
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
LIFE price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
ONE BAXTER PARKWAY DF2 2W
DEERFIELD, IL 60015
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PMVP | Director | 409,842 | $1.13 | $463.1K | -$568.3K | 11 | 2026-06-05 |
| MGTX | Director | — | $9.18 | — | $0 | 4 | 2022-06-09 |
| Innoviva, Inc. (THRX) Delisted | Director | 111,794 | $4.06 | $453.9K | $0 | 11 | 2014-03-25 |
| LIFE | Director | 1,122 | $42.30 | $47.5K | -$902.0K | 10 | 2013-04-26 |
| INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Director | 15,287 | $0.04 | $683 | $0 | 5 | 2011-05-19 |
| APPLIED BIOSYSTEMS INC. (CRA) Delisted | Director | 29,464 | — | — | $0 | 5 | 2007-12-05 |
Recent Filings · Page 3 of 5
47 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-04-30 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2011-06-17 | Innoviva, Inc. (THRX) Delisted | Other (J) | +20,028 | $0 | EDGAR |
| 2011-05-19 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-05-02 | LIFE | Grant (A) | — | $0 | EDGAR |
| 2011-04-28 | Innoviva, Inc. (THRX) Delisted | Grant (A) | +6,000 | $0 | EDGAR |
| 2011-03-16 | LIFE | Mixed | — | -$125.8K | EDGAR |
| 2010-12-27 | Innoviva, Inc. (THRX) Delisted | Other (J) | +768 | $0 | EDGAR |
| 2010-06-17 | Innoviva, Inc. (THRX) Delisted | Other (J) | +29,192 | $0 | EDGAR |
| 2010-05-27 | INFINITY PHARMACEUTICALS, INC. (INFI) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-05-03 | LIFE | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.